Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Mycoses 5 Leukemia, Myeloid, Acute 4 Recurrence 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Leukemia 3 Infections 3 Neutropenia 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Wilms Tumor 1 Triple Negative Breast Neoplasms 1 Torulopsis 1 Testicular Neoplasms 1 Teratoma, Testicular 1 Teratoma 1 Stem Cell Transplant Complications 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumours 1 Sezary Syndrome 1 Seminoma 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1

Interventions

Nivolumab 20 Ipilimumab 10 Surveys and Questionnaires 7 Paclitaxel 7 linrodostat 6 Standard of Care 6 Sirolimus 5 Gemcitabine 5 Bevacizumab 5 temsirolimus 4 relatlimab 4 Pemetrexed 4 Interviews as Topic 4 Docetaxel 4 Carboplatin 4 ARRY-334543 4 Vorinostat 3 Erlotinib Hydrochloride 3 Dasatinib 3 Cetuximab 3 regorafenib 2 olaparib 2 apatinib 2 anlotinib 2 abemaciclib 2 Trastuzumab 2 Sunitinib 2 Sorafenib 2 Olanzapine 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × Fluconazole × Clear all

NCT04193319 2019-12-10

Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡